(Q45855294)

17 December 2017

review article

1 reference

title

Clotting factor concentrates and immune function in haemophilic patients (English)

1 reference

17 December 2017

0 references

1 reference

Hoots K

1

1 reference

17 December 2017

Canty D

series ordinal

2

1 reference

17 December 2017

publication date

1 September 1998

1 reference

17 December 2017

published in

Haemophilia

1 reference

17 December 2017

volume

4

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

704-713

1 reference

17 December 2017

Absence of anti-human immunodeficiency virus types 1 and 2 seroconversion after the treatment of hemophilia A or von Willebrand's disease with pasteurized factor VIII concentrate

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

A functional defect in the early phase of the immune response observed in patients with hemophilia A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Interferon production in severe hemophiliacs with and without HIV antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Effects of factor VIII concentrates on the immune system in hemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Immunological alterations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Pathogenesis of infection with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

HIV infection and natural killer cytotoxicity in hemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Hepatitis B surface antigen circulating immune complexes (HBsAg-CICs) in patients with bleeding disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

HCV RNA levels and HIV infection: evidence for a viral interaction in haemophilic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Evidence for the aetiological role of blood‐borne virus infections in causing reduced lectin‐induced T‐cell proliferation in haemophilic boys

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Association of changes in monocyte antigen presentation and cytokine production in haemophilic boys with treatment and blood‐borne virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Tumor markers in ovarian cancer: a comparison between immunosuppressive acidic protein and alpha 1-acid glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Significance of immunoglobulin G subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Phenotypic and functional abnormalities in monocytes from patients with haemophilia A treated with factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Capacity to produce interleukin 2 is impaired in haemophilia in the absence and presence of HIV 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Unusually high incidence of tuberculosis among boys with haemophilia during an outbreak of the disease in hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Mechanisms of inhibition of T cell IL-2 secretion by factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Enhancement of human T cell responses to allogeneic stimuli by factor VIII concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Immunosuppressive property of a very high purity antihaemophilic preparation: a low molecular weight component inhibits an early step of PHA induced cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Purity of factor VIII concentrates and serial CD4 counts. The Transfusion Safety Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

High-purity factor concentrates in prevention of AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Consistently normal CD4+, CD8+ levels in haemophilic boys only treated with a virally safe factor VIII concentrate (BPL 8Y)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.1998.00172.X

10.1046/J.1365-2516.1998.00172.X

21 January 2018

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017